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Background Mesoblastic nephroma (Boland’s tumor) is
the most common benign renal tumor occurring in infants
and neonates. The most common presentation is
abdominal mass, but it can have varied presentations
because of associated paraneoplastic syndromes. Majority
of these tumors can be cured with surgical excision alone;
however, long-term follow-up is required for recurrence
or metastasis. Histopathologically, it is divided into two
subtypes: classic and cellular. The less common cellular
congenital mesoblastic nephromas have cellular elements
in them and tend to have a more malignant potential.
Patients and methods Two patients were studied over
a period of 2 years from June 2010 to June 2012.
Results By reporting two patients presenting in the
infantile period with classic congenital mesoblastic
nephromas, an attempt is made in this paper to
characterize the clinical behavior of this variety of renal
tumors. Hypertension and paraneoplastic syndromes can
be associated with this tumor. Herein we compare our
experience with other similar cases reported in the
literature.
Conclusion When renal tumors occur in infancy or at
neonatal age, mesoblastic nephroma should be kept in
mind. Association of hypertension and paraneoplastic
syndromes should be looked for. Surgery is usually
curative and postoperative follow-up for recurrence is
required, more so in cellular variety. Ann Pediatr Surg
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Introduction
Congenital mesoblastic nephroma (CMN) is a rare renal
tumor, with an incidence of 3.5% of all renal tumors [1].
Glick et al. [2] studied 101 renal tumors, of which 11
occurred at the age of 6 months or less, with CMN
occurring in seven cases. In 1967, Bolande et al. [3]
described CMN as a separate entity from congenital
Wilms’ tumor and emphasized on its benign nature [4].
The CMN generally presents as an asymptomatic
abdominal mass, sometimes accompanied by hematuria.
It can also have varied presentation because of para-
neoplastic syndromes. With the advancement in technol-
ogy, antenatal diagnosis is not unknown when it can lead
to polyhydramnios (71% of the gestations associated with
the tumor), hydrops, and premature delivery, in addition
to hypertension and hypercalcemia (owing to the tumor’s
secretion of a substance similar to parathormone) [5,6].
Nephrectomy is the treatment of choice and is alone
sufficient for good survival.
Patients and methods
Case 1
A 2-month-old male child presented with progressively
increasing abdominal mass. An abdominal ultrasound
(USG) scan revealed an echogenic mass in the upper
pole of the right kidney, with its outer part showing
concentric hyperechoic and hypoechoic layering, and the
center was of slightly lower echogenicity (ring sign). The
lower pole of the right kidney, left kidney, and adrenals
were normal. Computed tomographic (CT) scan of the
abdomen confirmed the presence of a low attenuation
mass in the upper pole of the right kidney, measuring
9.3 3 3 cm (Fig. 1). The right renal artery was
stretched around the inferior part of the mass. CT scan
of the chest was normal.
The hemogram, serum electrolytes, coagulation profile,
and creatinine were normal. Ionized calcium was border-
line high, initially at 1.39 mmol/l (0.9–1.3 mmol/l), but
repeat samples were within normal range. A right
nephrectomy with hilar and caval node excision was
performed.
The pathological findings were consistent with classic
CMN. The patient is now 2 years old and is asympto-
matic. Follow-up USG of these two patients showed no
recurrence.
Case 2
A 3-month-old male child presented with incidentally
detected abdominal lump and hypertension. On exam-
ination, the child was hypertensive and routine blood
investigations were normal. USG and CT scan revealed
mass arising from the upper pole of the right kidney.
Blood pressure was controlled and the child underwent
right nephrectomy (Fig. 2). On gross, the tumor was ill-
defined with no obvious capsule (Fig. 3). Microscopy
showed spindle cells and no atypia and was suggestive of
classic CMN (Fig. 4). Postoperative antihypertensive
medication was required for 2 weeks. The child is now
doing well at 2-year follow-up.
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Follow-up protocol at our institute for renal tumors was
carried out by pediatric oncologists. Close surveillance
was done in the first year by 3-monthly USG, and later on
by 6–12-monthly USG. CT scan was repeated only when
USG showed recurrence. Regular blood pressure was
monitored for tapering and stopping antihypertensive
medication.
Discussion
The vast majority of renal tumors encountered in infancy
are benign, representing mesenchymal hamartomatous
maldevelopment of the fetal kidney. In the older
literature (before 1975), leiomyomatous hamartoma and
fetal renal hamartomas were used synonymously with
CMN [7].
Although CMN is a rare tumor, it is the most common
renal tumor under 6 months of age and constitutes 3.4%
of all renal tumors [8]. Of the cases with CMN, 67% have
hypertension at presentation. Hypertension in CMN has
been explained on the basis of hyperreninemia, which is
seen in 80% of the cases of CMN. Overproduction of
renin may be primary, that is, it is secreted in the tumor,
Fig. 1




Gross appearance with no identified capsule.
Fig. 4
Microscopy showing classic congenital mesoblastic nephroma.
Rare pediatric renal tumor: classic CMN Bendre et al. 113
Copyright © Annals of Pediatric Surgery. Unauthorized reproduction of this article is prohibited.
or secondary because of ischemia of the renal tissue from
compression by the tumor, which is more likely in the
leiomyomatous type [9–11].
Although the most common presentation is an asympto-
matic abdominal mass, other clinical features include
hematuria, proteinuria, polyuria, vomiting, hypercalcemia,
jaundice, dehydration, azotemia, and electrolyte distur-
bances [11]. None of these were seen in our patient
association of Von Willebrand disease, which has also been
reported [12].
Imaging plays an important role not only in the detection
of renal tumors but also in the process of differential
diagnosis. Cystic renal masses are well delineated by
ultrasonography; however, solid lesions may require
further evaluation by CT or MRI [13]. On USG imaging,
CMN appears typically as a well-defined, solid, homo-
geneous lesion of a fine-to-medium coarse basic texture.
There may be some heterogeneity because of the
hypoechoic areas of hemorrhage or necrosis, which were
not seen in our case. A distinctive ‘ring sign’ may be seen
in typical intrarenal CMN [14], as also seen in our
patient. Although most cases of CMN have been
diagnosed postnatally, with advances in the imaging
technology, an increasing number of cases are being
detected on antenatal scans [15]. Irsutti et al. [16] have
discussed the antenatal USG and MRI features of CMN.
Childhood renal tumors were classified according to the
‘Stockholm classification’, in which CMN is included in
low-risk group and staged as per other renal tumors into
ST1-5 (SIOP staging).
Cystic change with hemorrhage and necrosis has been
reported to be of significance in determining the
prognosis of mesoblastic nephromas. Whereas Garbyal
et al. [17] consider it to be of adverse significance, the
cystic CMN reported by Murthi et al. [18] had a good
outcome. Both patients in our series had cystic change
within the tumor. Both of them with small cysts had
difficult excision, but no intraoperative tumor spillage.
Therefore, apart from contributing adversely to the tumor
dissection, the presence of cysts and hemorrhage most
probably does not have any prognostic value.
Recent studies have shown that the classic and cellular
variants have genetic differences. Only the cellular
variant shows translocation (12; 15) (p13; q25), which
leads to the ETV6-NTRK3 gene fusion. There have been
varied findings in mixed subtypes [19].
Surgery is the primary modality of treatment. The role of
chemotherapy for the treatment of CMNs is controver-
sial. It is well appreciated that the definitive management
for a CMN is a surgical excision, with disease-free
margins. In the event of a recurrence or with an
inoperable tumor, chemotherapy may be beneficial.
Kulkarni et al. [20] have stated the role of diagnostic
cytopathology in differentiating mesoblastic nephroma
from other renal tumors.
Conclusion
CMN, though rare, should be considered in differential
diagnosis of renal mass occurring in infancy. Hypertension
should be looked for and stabilized before surgical
intervention for best outcome. Diagnosis is made best
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Nephroblastoma Study Group. Mesoblastic nephroma: a report from the
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